夏威夷就 Plavix 警告标签问题与百时美施贵宝和赛诺菲达成 7 亿美元和解协议

路透中文
10 May
夏威夷就 Plavix 警告标签问题与百时美<a href="https://laohu8.com/S/BMY">施贵宝</a>和<a href="https://laohu8.com/S/0O59.UK">赛诺菲</a>达成 7 亿美元和解协议

路透5月10日 - 夏威夷州周五表示,它与制药公司百时美施贵宝BMY.N和法国制药公司赛诺菲SASY.PA旗下公司就血液稀释剂Plavix的健康风险警示标签一案达成了7亿美元的和解协议。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10